Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

The long wait: What 24 Supreme Court references reveal about judicial delay

Delhi court issues fresh summons to YouTuber Dhruv Rathee in 2018 defamation case

Delhi High Court rules it can execute commercial decrees below ₹2 crore if original suit was within its jurisdiction

Only 45 stations closed, no complete metro ban: DMRC to Supreme Court; Chairperson tenders apology

NCLAT stays insolvency proceedings against Polycab India over ₹2.78 crore debt

SCROLL FOR NEXT